Skip to main content
Signal8

Sermon Charles

SEC insider (Form 3/4/5 filer). CIK 0001687318. General Counsel at Mereo BioPharma Group plc (MREO). 7 reported Form 4/5 transactions since Sep 2024; latest on Feb 1, 2026. Located in LONDON, X0.

Companies Sermon Charles has filed insider reports for

  • Mereo BioPharma Group plc (MREO): Officer, General Counsel
Sermon Charles profile photo

Sermon Charles

CIK: 0001687318

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)2 (28.6%)

Position reduction

Option Exercises (M)1 (14.3%)

Derivative conversions

Awards (A)4 (57.1%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

Mereo BioPharma Group plc logo
MREO

Mereo BioPharma Group plc

Officer

Discretionary Trading P&L

Holdings

Transaction History (7 total)

  • Mereo BioPharma Group plc logo
    MREO

    Mereo BioPharma Group plc

    Feb 1, 2026
    Award

    Share Options (Right to buy)

    Direct
    315.8K shares-
  • Mereo BioPharma Group plc logo
    MREO

    Mereo BioPharma Group plc

    Feb 1, 2026
    Award

    Share Options (Right to buy)

    Direct
    105.3K shares-
  • Mereo BioPharma Group plc logo
    MREO

    Mereo BioPharma Group plc

    Feb 1, 2026
    Award

    Share Options (Right to buy)

    Direct
    295K shares-
  • Mereo BioPharma Group plc logo
    MREO

    Mereo BioPharma Group plc

    Jan 25, 2025
    Award

    Share Options (Right to buy)

    Direct
    262K shares-
  • Mereo BioPharma Group plc logo
    MREO

    Mereo BioPharma Group plc

    Sep 13, 2024
    Sale
    Direct
    20.9K shares at avg. $4.22$88K
  • Mereo BioPharma Group plc logo
    MREO

    Mereo BioPharma Group plc

    Sep 12, 2024
    Sale
    Direct
    10K shares at avg. $4.47$45K
  • Mereo BioPharma Group plc logo
    MREO

    Mereo BioPharma Group plc

    Sep 11, 2024
    Exercise
    Direct
    65.6K shares-

1-7 of 7